Julie Haines
Concepts (380)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Metabolomics | 16 | 2019 | 732 | 2.190 |
Why?
| | Erythrocytes | 12 | 2019 | 748 | 1.710 |
Why?
| | Cysteine | 8 | 2019 | 211 | 1.450 |
Why?
| | Nitrogen Oxides | 6 | 2014 | 46 | 1.370 |
Why?
| | Blood Preservation | 9 | 2019 | 346 | 1.300 |
Why?
| | Metabolome | 11 | 2019 | 388 | 1.290 |
Why?
| | Oxidation-Reduction | 13 | 2019 | 1067 | 0.730 |
Why?
| | Nitric Oxide Donors | 2 | 2012 | 19 | 0.710 |
Why?
| | Isotope Labeling | 3 | 2026 | 82 | 0.690 |
Why?
| | Phosphines | 4 | 2014 | 18 | 0.690 |
Why?
| | Peroxiredoxins | 3 | 2018 | 25 | 0.690 |
Why?
| | Mass Spectrometry | 8 | 2026 | 730 | 0.690 |
Why?
| | Sulfenic Acids | 3 | 2016 | 6 | 0.650 |
Why?
| | Hydrogen Peroxide | 3 | 2018 | 335 | 0.630 |
Why?
| | Proteins | 5 | 2016 | 1023 | 0.610 |
Why?
| | Eye Diseases, Hereditary | 1 | 2018 | 15 | 0.550 |
Why?
| | Erythrocyte Transfusion | 4 | 2019 | 225 | 0.550 |
Why?
| | Hydroxylamine | 1 | 2017 | 7 | 0.530 |
Why?
| | Glycolysis | 7 | 2019 | 340 | 0.530 |
Why?
| | Vitreous Body | 1 | 2018 | 117 | 0.520 |
Why?
| | Retinal Detachment | 1 | 2018 | 73 | 0.520 |
Why?
| | Diabetic Retinopathy | 1 | 2018 | 209 | 0.460 |
Why?
| | Hernias, Diaphragmatic, Congenital | 2 | 2019 | 221 | 0.450 |
Why?
| | Lipogenesis | 1 | 2026 | 62 | 0.450 |
Why?
| | Proteome | 2 | 2018 | 514 | 0.450 |
Why?
| | Blood Proteins | 1 | 2017 | 239 | 0.430 |
Why?
| | Leukemia, Myeloid, Acute | 3 | 2019 | 686 | 0.430 |
Why?
| | Chondrocytes | 2 | 2018 | 232 | 0.430 |
Why?
| | Neoplastic Stem Cells | 2 | 2019 | 409 | 0.430 |
Why?
| | Succinic Acid | 4 | 2018 | 46 | 0.420 |
Why?
| | Proteomics | 4 | 2018 | 1188 | 0.420 |
Why?
| | Neural Stem Cells | 1 | 2026 | 168 | 0.400 |
Why?
| | Plasma | 3 | 2019 | 223 | 0.400 |
Why?
| | Oxidative Phosphorylation | 3 | 2019 | 209 | 0.390 |
Why?
| | Extracellular Matrix | 1 | 2017 | 562 | 0.390 |
Why?
| | Triazenes | 1 | 2012 | 6 | 0.380 |
Why?
| | Cardiotonic Agents | 1 | 2012 | 94 | 0.360 |
Why?
| | Sulfhydryl Compounds | 2 | 2014 | 189 | 0.360 |
Why?
| | Oxidative Stress | 5 | 2019 | 1356 | 0.350 |
Why?
| | Sulfones | 1 | 2012 | 127 | 0.350 |
Why?
| | Lipids | 2 | 2019 | 707 | 0.340 |
Why?
| | Amino Acids | 3 | 2019 | 519 | 0.340 |
Why?
| | Stomach Ulcer | 1 | 2011 | 12 | 0.340 |
Why?
| | Indomethacin | 1 | 2011 | 76 | 0.330 |
Why?
| | Shock, Hemorrhagic | 3 | 2018 | 199 | 0.320 |
Why?
| | Macrophages | 3 | 2018 | 1507 | 0.320 |
Why?
| | Hydroxamic Acids | 1 | 2011 | 94 | 0.320 |
Why?
| | Prodrugs | 1 | 2011 | 52 | 0.320 |
Why?
| | Purines | 3 | 2018 | 187 | 0.310 |
Why?
| | Heart | 2 | 2019 | 626 | 0.310 |
Why?
| | Animals | 26 | 2026 | 38030 | 0.300 |
Why?
| | Energy Metabolism | 5 | 2019 | 935 | 0.300 |
Why?
| | Mitochondria | 3 | 2017 | 992 | 0.300 |
Why?
| | Lipid Metabolism | 3 | 2019 | 529 | 0.300 |
Why?
| | Electron Transport Complex II | 1 | 2019 | 27 | 0.290 |
Why?
| | Nitric Oxide | 2 | 2012 | 892 | 0.290 |
Why?
| | Mitogen-Activated Protein Kinase 9 | 1 | 2018 | 17 | 0.280 |
Why?
| | Organogenesis | 1 | 2019 | 63 | 0.280 |
Why?
| | Gluconates | 1 | 2018 | 4 | 0.280 |
Why?
| | Antihypertensive Agents | 1 | 2012 | 519 | 0.280 |
Why?
| | Antacids | 1 | 2018 | 16 | 0.270 |
Why?
| | Rejuvenation | 1 | 2018 | 18 | 0.270 |
Why?
| | Receptors, CCR2 | 1 | 2018 | 39 | 0.270 |
Why?
| | Guanosine | 1 | 2018 | 40 | 0.270 |
Why?
| | Lung | 3 | 2019 | 4106 | 0.270 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2011 | 345 | 0.260 |
Why?
| | Protein Processing, Post-Translational | 3 | 2018 | 471 | 0.260 |
Why?
| | Glycogen | 1 | 2017 | 55 | 0.260 |
Why?
| | Tracheal Stenosis | 1 | 2018 | 39 | 0.260 |
Why?
| | Interleukin-1beta | 2 | 2018 | 389 | 0.260 |
Why?
| | Glucose | 3 | 2026 | 1048 | 0.250 |
Why?
| | Airway Obstruction | 1 | 2019 | 153 | 0.250 |
Why?
| | Cryopreservation | 2 | 2018 | 113 | 0.250 |
Why?
| | Fatty Acids | 2 | 2019 | 457 | 0.250 |
Why?
| | Cellular Reprogramming | 1 | 2017 | 98 | 0.250 |
Why?
| | Reactive Oxygen Species | 6 | 2019 | 611 | 0.250 |
Why?
| | Liver | 3 | 2018 | 1896 | 0.240 |
Why?
| | High-Throughput Screening Assays | 2 | 2019 | 176 | 0.240 |
Why?
| | Iron | 1 | 2018 | 357 | 0.230 |
Why?
| | Calpain | 1 | 2016 | 61 | 0.230 |
Why?
| | Troponin T | 1 | 2016 | 63 | 0.230 |
Why?
| | Humans | 39 | 2026 | 145474 | 0.230 |
Why?
| | Blood Pressure | 1 | 2012 | 1779 | 0.230 |
Why?
| | Cholestasis | 1 | 2018 | 214 | 0.220 |
Why?
| | src-Family Kinases | 1 | 2016 | 92 | 0.220 |
Why?
| | Temperature | 1 | 2018 | 633 | 0.220 |
Why?
| | Wounds and Injuries | 3 | 2018 | 961 | 0.220 |
Why?
| | Calcium Channels, L-Type | 1 | 2016 | 117 | 0.220 |
Why?
| | Cycloparaffins | 1 | 2014 | 2 | 0.210 |
Why?
| | Bridged Bicyclo Compounds | 1 | 2014 | 13 | 0.210 |
Why?
| | Fetus | 1 | 2019 | 804 | 0.210 |
Why?
| | NF-kappa B | 1 | 2018 | 666 | 0.210 |
Why?
| | Kynurenine | 1 | 2025 | 114 | 0.210 |
Why?
| | Carbon Isotopes | 3 | 2026 | 143 | 0.210 |
Why?
| | Peptide Fragments | 2 | 2016 | 693 | 0.200 |
Why?
| | Acute Lung Injury | 1 | 2017 | 305 | 0.200 |
Why?
| | Cells | 1 | 2014 | 25 | 0.200 |
Why?
| | Dithiothreitol | 1 | 2013 | 19 | 0.200 |
Why?
| | Dendritic Cells | 1 | 2017 | 499 | 0.200 |
Why?
| | Biomarkers | 6 | 2025 | 4295 | 0.200 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 3 | 2014 | 174 | 0.190 |
Why?
| | Osteoarthritis | 1 | 2016 | 200 | 0.190 |
Why?
| | Nucleic Acids | 1 | 2014 | 70 | 0.190 |
Why?
| | Fluorescent Dyes | 1 | 2014 | 333 | 0.190 |
Why?
| | Cartilage, Articular | 1 | 2016 | 349 | 0.170 |
Why?
| | Glutamine | 3 | 2026 | 109 | 0.170 |
Why?
| | Oxidants | 2 | 2019 | 99 | 0.170 |
Why?
| | DNA Damage | 1 | 2014 | 437 | 0.160 |
Why?
| | Biomedical Research | 1 | 2017 | 717 | 0.160 |
Why?
| | Disease Models, Animal | 7 | 2019 | 4560 | 0.160 |
Why?
| | Structure-Activity Relationship | 2 | 2012 | 563 | 0.160 |
Why?
| | S-Nitrosothiols | 1 | 2010 | 5 | 0.160 |
Why?
| | S-Nitrosoglutathione | 1 | 2010 | 8 | 0.160 |
Why?
| | Hemeproteins | 1 | 2010 | 8 | 0.160 |
Why?
| | Mice | 11 | 2019 | 18329 | 0.160 |
Why?
| | Molecular Structure | 3 | 2012 | 486 | 0.160 |
Why?
| | Models, Biological | 1 | 2017 | 1764 | 0.150 |
Why?
| | Kinetics | 3 | 2014 | 1567 | 0.150 |
Why?
| | Biocatalysis | 2 | 2014 | 67 | 0.150 |
Why?
| | Leukopoiesis | 1 | 2019 | 11 | 0.150 |
Why?
| | Mice, Inbred C57BL | 6 | 2019 | 5983 | 0.150 |
Why?
| | NADPH Oxidase 2 | 1 | 2019 | 32 | 0.150 |
Why?
| | Myeloid Progenitor Cells | 1 | 2019 | 16 | 0.150 |
Why?
| | Torpor | 1 | 2019 | 19 | 0.140 |
Why?
| | Cell Self Renewal | 1 | 2019 | 52 | 0.140 |
Why?
| | Heart Failure, Diastolic | 1 | 2019 | 23 | 0.140 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2014 | 143 | 0.140 |
Why?
| | Cardio-Renal Syndrome | 1 | 2019 | 20 | 0.140 |
Why?
| | Asparagine | 1 | 2018 | 35 | 0.140 |
Why?
| | Xanthine | 1 | 2018 | 7 | 0.140 |
Why?
| | Blood Banks | 1 | 2018 | 50 | 0.140 |
Why?
| | Aspartic Acid | 1 | 2018 | 88 | 0.140 |
Why?
| | Salmonella typhimurium | 1 | 2010 | 188 | 0.140 |
Why?
| | Arousal | 1 | 2019 | 157 | 0.140 |
Why?
| | Proteostasis | 1 | 2018 | 27 | 0.130 |
Why?
| | Erythrocytes, Abnormal | 1 | 2017 | 14 | 0.130 |
Why?
| | Methods | 1 | 2017 | 68 | 0.130 |
Why?
| | Hemoglobin A | 1 | 2017 | 21 | 0.130 |
Why?
| | Hemoglobin, Sickle | 1 | 2017 | 20 | 0.130 |
Why?
| | Hypoxanthine | 1 | 2017 | 11 | 0.130 |
Why?
| | Benzeneacetamides | 1 | 2017 | 8 | 0.130 |
Why?
| | Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2017 | 18 | 0.130 |
Why?
| | Glutaminase | 1 | 2017 | 11 | 0.130 |
Why?
| | Polypyrimidine Tract-Binding Protein | 1 | 2017 | 16 | 0.130 |
Why?
| | Pyruvate Kinase | 1 | 2017 | 28 | 0.130 |
Why?
| | Benzothiazoles | 1 | 2017 | 39 | 0.130 |
Why?
| | Thiadiazoles | 1 | 2017 | 25 | 0.130 |
Why?
| | Sphingosine | 1 | 2017 | 47 | 0.130 |
Why?
| | Sciuridae | 1 | 2019 | 152 | 0.130 |
Why?
| | Rabbits | 2 | 2019 | 652 | 0.130 |
Why?
| | fms-Like Tyrosine Kinase 3 | 1 | 2017 | 51 | 0.130 |
Why?
| | Solubility | 1 | 2017 | 240 | 0.130 |
Why?
| | Lysophospholipids | 1 | 2017 | 80 | 0.130 |
Why?
| | Chromatography, Affinity | 1 | 2017 | 80 | 0.120 |
Why?
| | Aging | 2 | 2018 | 1969 | 0.120 |
Why?
| | Models, Molecular | 3 | 2018 | 1598 | 0.120 |
Why?
| | Phenylurea Compounds | 1 | 2017 | 119 | 0.120 |
Why?
| | Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+) | 1 | 2016 | 7 | 0.120 |
Why?
| | Leukemia | 1 | 2019 | 246 | 0.120 |
Why?
| | Time Factors | 5 | 2025 | 7123 | 0.120 |
Why?
| | Signal Transduction | 4 | 2018 | 5216 | 0.120 |
Why?
| | Fibronectins | 2 | 2018 | 136 | 0.120 |
Why?
| | Tandem Mass Spectrometry | 2 | 2016 | 572 | 0.120 |
Why?
| | Saline Solution, Hypertonic | 1 | 2016 | 43 | 0.120 |
Why?
| | Extracellular Matrix Proteins | 1 | 2017 | 156 | 0.120 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2017 | 331 | 0.120 |
Why?
| | Chromatography, High Pressure Liquid | 4 | 2018 | 592 | 0.120 |
Why?
| | Lactic Acid | 1 | 2018 | 295 | 0.120 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2016 | 105 | 0.120 |
Why?
| | Adenosine Triphosphate | 2 | 2019 | 500 | 0.120 |
Why?
| | Esters | 2 | 2011 | 71 | 0.120 |
Why?
| | Apolipoproteins | 1 | 2015 | 38 | 0.120 |
Why?
| | Reperfusion Injury | 1 | 2018 | 293 | 0.120 |
Why?
| | Stroke | 1 | 2025 | 1270 | 0.110 |
Why?
| | Ischemia | 1 | 2019 | 422 | 0.110 |
Why?
| | Muscle, Skeletal | 1 | 2016 | 1789 | 0.110 |
Why?
| | Chromatography, Liquid | 2 | 2019 | 450 | 0.110 |
Why?
| | Inflammation Mediators | 2 | 2019 | 506 | 0.110 |
Why?
| | Workflow | 1 | 2017 | 183 | 0.110 |
Why?
| | Lipoproteins, HDL | 1 | 2015 | 100 | 0.110 |
Why?
| | Cyclohexanones | 2 | 2016 | 9 | 0.110 |
Why?
| | Protein Stability | 2 | 2016 | 176 | 0.110 |
Why?
| | 2,3-Diphosphoglycerate | 2 | 2018 | 32 | 0.100 |
Why?
| | Healthy Volunteers | 2 | 2019 | 219 | 0.100 |
Why?
| | Peroxiredoxin III | 1 | 2013 | 1 | 0.100 |
Why?
| | Amino Acid Sequence | 2 | 2018 | 2129 | 0.100 |
Why?
| | Sulfinic Acids | 1 | 2013 | 6 | 0.100 |
Why?
| | Rats, Sprague-Dawley | 3 | 2018 | 2524 | 0.100 |
Why?
| | Nitrogen Isotopes | 2 | 2017 | 69 | 0.100 |
Why?
| | Anemia, Sickle Cell | 1 | 2017 | 318 | 0.100 |
Why?
| | Sulfonamides | 2 | 2018 | 583 | 0.100 |
Why?
| | Disulfides | 1 | 2013 | 94 | 0.100 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2013 | 387 | 0.090 |
Why?
| | Half-Life | 1 | 2012 | 155 | 0.090 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2016 | 534 | 0.090 |
Why?
| | Enzyme Activation | 1 | 2013 | 762 | 0.090 |
Why?
| | Female | 12 | 2025 | 78844 | 0.080 |
Why?
| | Swine | 3 | 2018 | 825 | 0.080 |
Why?
| | Carrageenan | 1 | 2011 | 8 | 0.080 |
Why?
| | Magnetic Resonance Spectroscopy | 2 | 2017 | 627 | 0.080 |
Why?
| | MicroRNAs | 1 | 2017 | 686 | 0.080 |
Why?
| | Gastric Mucosa | 1 | 2011 | 54 | 0.080 |
Why?
| | Naproxen | 1 | 2011 | 21 | 0.080 |
Why?
| | Tryptophan | 2 | 2025 | 182 | 0.080 |
Why?
| | Stereoisomerism | 1 | 2011 | 103 | 0.080 |
Why?
| | Cyclooxygenase Inhibitors | 1 | 2011 | 82 | 0.080 |
Why?
| | Critical Illness | 1 | 2017 | 900 | 0.080 |
Why?
| | Acute Kidney Injury | 1 | 2019 | 875 | 0.080 |
Why?
| | Rats | 3 | 2018 | 5584 | 0.080 |
Why?
| | Cells, Cultured | 3 | 2019 | 4148 | 0.080 |
Why?
| | Ibuprofen | 1 | 2011 | 87 | 0.080 |
Why?
| | Male | 12 | 2025 | 72842 | 0.080 |
Why?
| | Edema | 1 | 2011 | 125 | 0.080 |
Why?
| | Epithelial Cells | 1 | 2016 | 1131 | 0.080 |
Why?
| | Hypoxia | 1 | 2017 | 1199 | 0.080 |
Why?
| | Cell Line | 2 | 2016 | 2823 | 0.070 |
Why?
| | Plasticizers | 1 | 2019 | 18 | 0.070 |
Why?
| | Molecular Sequence Data | 1 | 2013 | 2883 | 0.070 |
Why?
| | Succinate Dehydrogenase | 1 | 2019 | 65 | 0.070 |
Why?
| | Caspases, Initiator | 1 | 2018 | 16 | 0.070 |
Why?
| | Liver X Receptors | 1 | 2018 | 29 | 0.070 |
Why?
| | Pulmonary Surfactants | 1 | 2019 | 105 | 0.070 |
Why?
| | Vasoconstrictor Agents | 1 | 2019 | 150 | 0.070 |
Why?
| | Organ Size | 1 | 2019 | 461 | 0.070 |
Why?
| | Transplantation, Autologous | 1 | 2019 | 300 | 0.070 |
Why?
| | Glycogen Phosphorylase | 1 | 2017 | 2 | 0.070 |
Why?
| | Methionine | 1 | 2018 | 161 | 0.070 |
Why?
| | Solutions | 1 | 2018 | 159 | 0.070 |
Why?
| | Caspase 1 | 1 | 2018 | 145 | 0.070 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 2 | 2019 | 192 | 0.060 |
Why?
| | Azacitidine | 1 | 2018 | 157 | 0.060 |
Why?
| | Biological Transport | 1 | 2018 | 424 | 0.060 |
Why?
| | Cell Respiration | 1 | 2017 | 105 | 0.060 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2018 | 239 | 0.060 |
Why?
| | Glutathione | 1 | 2019 | 370 | 0.060 |
Why?
| | Immune System | 1 | 2018 | 180 | 0.060 |
Why?
| | Receptors, Interleukin-1 | 1 | 2018 | 211 | 0.060 |
Why?
| | Parenteral Nutrition | 1 | 2018 | 102 | 0.060 |
Why?
| | Caspases | 1 | 2018 | 233 | 0.060 |
Why?
| | Mutation | 2 | 2013 | 4075 | 0.060 |
Why?
| | Trachea | 1 | 2019 | 258 | 0.060 |
Why?
| | Lipoproteins | 1 | 2018 | 166 | 0.060 |
Why?
| | Hepatocytes | 1 | 2018 | 224 | 0.060 |
Why?
| | Hemoglobins | 2 | 2018 | 386 | 0.060 |
Why?
| | In Vitro Techniques | 1 | 2018 | 1048 | 0.060 |
Why?
| | Immunologic Factors | 1 | 2019 | 260 | 0.060 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2018 | 207 | 0.060 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2018 | 280 | 0.060 |
Why?
| | Muscle Fibers, Fast-Twitch | 1 | 2016 | 18 | 0.060 |
Why?
| | Cell Line, Tumor | 2 | 2018 | 3542 | 0.060 |
Why?
| | Matrix Metalloproteinase 13 | 1 | 2016 | 25 | 0.060 |
Why?
| | Muscle Fibers, Slow-Twitch | 1 | 2016 | 24 | 0.060 |
Why?
| | History, Ancient | 1 | 2016 | 53 | 0.060 |
Why?
| | Hypertension, Pulmonary | 1 | 2017 | 1957 | 0.060 |
Why?
| | Analysis of Variance | 1 | 2018 | 1300 | 0.060 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2016 | 88 | 0.060 |
Why?
| | Cell Proliferation | 2 | 2017 | 2507 | 0.060 |
Why?
| | Cell Lineage | 1 | 2017 | 377 | 0.060 |
Why?
| | Pregnancy | 2 | 2019 | 7202 | 0.060 |
Why?
| | Immunoblotting | 1 | 2016 | 295 | 0.060 |
Why?
| | Vasodilation | 1 | 2018 | 521 | 0.060 |
Why?
| | Cytokines | 2 | 2017 | 2067 | 0.050 |
Why?
| | Muscle Fatigue | 1 | 2016 | 98 | 0.050 |
Why?
| | Gene Knockdown Techniques | 1 | 2016 | 333 | 0.050 |
Why?
| | Sequence Analysis, RNA | 1 | 2017 | 442 | 0.050 |
Why?
| | Inflammation | 1 | 2016 | 2878 | 0.050 |
Why?
| | Multivariate Analysis | 1 | 2018 | 1547 | 0.050 |
Why?
| | Microscopy, Confocal | 1 | 2016 | 319 | 0.050 |
Why?
| | Peptide Mapping | 1 | 2014 | 62 | 0.050 |
Why?
| | Molecular Probes | 1 | 2014 | 33 | 0.050 |
Why?
| | Homeostasis | 1 | 2018 | 642 | 0.050 |
Why?
| | Cell Survival | 1 | 2017 | 1100 | 0.050 |
Why?
| | Iodoacetamide | 1 | 2013 | 5 | 0.050 |
Why?
| | Ethylmaleimide | 1 | 2013 | 18 | 0.050 |
Why?
| | Methyl Methanesulfonate | 1 | 2013 | 7 | 0.050 |
Why?
| | Isometric Contraction | 1 | 2016 | 190 | 0.050 |
Why?
| | Lipopolysaccharides | 1 | 2017 | 858 | 0.050 |
Why?
| | Radiation, Ionizing | 1 | 2014 | 86 | 0.050 |
Why?
| | Oxygen | 1 | 2018 | 978 | 0.050 |
Why?
| | HeLa Cells | 1 | 2014 | 632 | 0.050 |
Why?
| | Aged, 80 and over | 2 | 2025 | 8333 | 0.050 |
Why?
| | Cell Nucleus | 1 | 2016 | 588 | 0.050 |
Why?
| | Myocardium | 2 | 2019 | 934 | 0.050 |
Why?
| | Hypoglycemia | 1 | 2017 | 479 | 0.050 |
Why?
| | Biomechanical Phenomena | 1 | 2016 | 857 | 0.050 |
Why?
| | Mice, Transgenic | 2 | 2017 | 2188 | 0.050 |
Why?
| | Ascorbic Acid | 1 | 2013 | 184 | 0.040 |
Why?
| | Up-Regulation | 1 | 2025 | 847 | 0.040 |
Why?
| | Adult | 5 | 2019 | 40777 | 0.040 |
Why?
| | Pneumonia | 1 | 2017 | 636 | 0.040 |
Why?
| | Colorado | 2 | 2025 | 4553 | 0.040 |
Why?
| | Promoter Regions, Genetic | 1 | 2016 | 1246 | 0.040 |
Why?
| | Microbiota | 1 | 2018 | 730 | 0.040 |
Why?
| | Nitrosation | 1 | 2010 | 8 | 0.040 |
Why?
| | Gene Expression Profiling | 1 | 2017 | 1767 | 0.040 |
Why?
| | Horseradish Peroxidase | 1 | 2010 | 26 | 0.040 |
Why?
| | Myoglobin | 1 | 2010 | 12 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2014 | 2028 | 0.040 |
Why?
| | Guanylate Cyclase | 1 | 2010 | 38 | 0.040 |
Why?
| | Electron Transport Complex IV | 1 | 2010 | 61 | 0.040 |
Why?
| | Catalase | 1 | 2010 | 134 | 0.040 |
Why?
| | Protein Binding | 1 | 2016 | 2238 | 0.040 |
Why?
| | Aza Compounds | 1 | 2009 | 12 | 0.040 |
Why?
| | Cell Differentiation | 1 | 2017 | 2046 | 0.040 |
Why?
| | Transcription, Genetic | 1 | 2016 | 1454 | 0.040 |
Why?
| | Reproducibility of Results | 1 | 2017 | 3413 | 0.040 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2010 | 161 | 0.040 |
Why?
| | Cryoprotective Agents | 1 | 2018 | 11 | 0.040 |
Why?
| | Osmotic Fragility | 1 | 2018 | 12 | 0.040 |
Why?
| | Erythrocyte Indices | 1 | 2018 | 33 | 0.040 |
Why?
| | Erythrocyte Deformability | 1 | 2018 | 23 | 0.040 |
Why?
| | Gene Expression Regulation | 1 | 2018 | 2597 | 0.040 |
Why?
| | Sulfur | 1 | 2019 | 60 | 0.030 |
Why?
| | Glycerol | 1 | 2018 | 90 | 0.030 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2018 | 196 | 0.030 |
Why?
| | Transplantation, Heterologous | 1 | 2018 | 170 | 0.030 |
Why?
| | Water | 1 | 2011 | 445 | 0.030 |
Why?
| | Hibernation | 1 | 2019 | 82 | 0.030 |
Why?
| | Methylation | 1 | 2018 | 242 | 0.030 |
Why?
| | Deamination | 1 | 2017 | 6 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2016 | 3623 | 0.030 |
Why?
| | Forkhead Transcription Factors | 1 | 2019 | 207 | 0.030 |
Why?
| | Antagomirs | 1 | 2017 | 12 | 0.030 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2018 | 124 | 0.030 |
Why?
| | Naphthoquinones | 1 | 2017 | 20 | 0.030 |
Why?
| | Amino Acid Motifs | 1 | 2018 | 219 | 0.030 |
Why?
| | Liquid-Liquid Extraction | 1 | 2017 | 13 | 0.030 |
Why?
| | Crush Injuries | 1 | 2017 | 14 | 0.030 |
Why?
| | Pentose Phosphate Pathway | 1 | 2017 | 55 | 0.030 |
Why?
| | Freezing | 1 | 2017 | 83 | 0.030 |
Why?
| | Lactates | 1 | 2017 | 82 | 0.030 |
Why?
| | Swine, Miniature | 1 | 2017 | 89 | 0.030 |
Why?
| | Reference Standards | 1 | 2017 | 177 | 0.030 |
Why?
| | Cell Adhesion | 1 | 2018 | 451 | 0.030 |
Why?
| | Antineoplastic Agents | 1 | 2018 | 2214 | 0.030 |
Why?
| | Primates | 1 | 2018 | 133 | 0.030 |
Why?
| | Mice, Nude | 1 | 2018 | 679 | 0.030 |
Why?
| | Chemical Fractionation | 1 | 2016 | 29 | 0.030 |
Why?
| | Metabolic Networks and Pathways | 1 | 2017 | 174 | 0.030 |
Why?
| | Femoral Fractures | 1 | 2017 | 84 | 0.030 |
Why?
| | Crystallography, X-Ray | 1 | 2018 | 486 | 0.030 |
Why?
| | Protein Folding | 1 | 2018 | 276 | 0.030 |
Why?
| | Bronchioles | 1 | 2016 | 29 | 0.030 |
Why?
| | Risk Factors | 2 | 2025 | 10885 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2019 | 741 | 0.030 |
Why?
| | Databases, Protein | 1 | 2016 | 88 | 0.030 |
Why?
| | Middle Aged | 3 | 2025 | 36215 | 0.030 |
Why?
| | Infant, Newborn | 1 | 2018 | 6447 | 0.030 |
Why?
| | Cell Cycle Checkpoints | 1 | 2016 | 97 | 0.030 |
Why?
| | Protein Isoforms | 1 | 2017 | 397 | 0.030 |
Why?
| | Apolipoprotein L1 | 1 | 2015 | 14 | 0.030 |
Why?
| | Proteolysis | 1 | 2016 | 172 | 0.030 |
Why?
| | Neurodegenerative Diseases | 1 | 2018 | 142 | 0.030 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2017 | 218 | 0.030 |
Why?
| | Hemolysis | 1 | 2017 | 242 | 0.030 |
Why?
| | Echocardiography | 1 | 2019 | 647 | 0.030 |
Why?
| | RNA Interference | 1 | 2017 | 475 | 0.030 |
Why?
| | Mice, Inbred NOD | 1 | 2017 | 613 | 0.030 |
Why?
| | Glutamic Acid | 1 | 2017 | 255 | 0.030 |
Why?
| | Magnetic Resonance Imaging | 1 | 2018 | 3904 | 0.030 |
Why?
| | Alternative Splicing | 1 | 2017 | 247 | 0.030 |
Why?
| | Cattle | 1 | 2017 | 946 | 0.030 |
Why?
| | Risk Assessment | 1 | 2025 | 3747 | 0.030 |
Why?
| | Aged | 2 | 2025 | 26153 | 0.030 |
Why?
| | Trauma Centers | 1 | 2017 | 466 | 0.030 |
Why?
| | Intestines | 1 | 2017 | 354 | 0.030 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2017 | 934 | 0.030 |
Why?
| | Genetic Association Studies | 1 | 2015 | 369 | 0.030 |
Why?
| | Fibroblasts | 1 | 2017 | 1025 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2017 | 2121 | 0.020 |
Why?
| | Kidney Diseases | 1 | 2015 | 425 | 0.020 |
Why?
| | Kidney | 1 | 2019 | 1497 | 0.020 |
Why?
| | Endothelium, Vascular | 1 | 2017 | 956 | 0.020 |
Why?
| | Peptides | 1 | 2016 | 998 | 0.020 |
Why?
| | Genetic Variation | 1 | 2015 | 972 | 0.020 |
Why?
| | Phenotype | 1 | 2018 | 3155 | 0.020 |
Why?
| | Prognosis | 1 | 2017 | 4316 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2015 | 2378 | 0.020 |
Why?
| | Brain | 1 | 2016 | 2947 | 0.010 |
Why?
| | Cardiovascular Diseases | 1 | 2015 | 2187 | 0.010 |
Why?
|
|
Haines's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|